No Data
No Data
Harbin Medisan Pharmaceutical (002900.SZ): As of July 10th, the company has 32,178 shareholders.
Harbin Medisan Pharmaceutical (002900.SZ) stated on the investor interaction platform on July 15th that according to the latest data from China Securities Depository and Clearing Co. Ltd., as of July 10th, 2024, the number of shareholders in the company was 32,178.
Harbin Medisan Pharmaceutical: 2024 Interim Performance Forecast
Harbin Medisan Pharmaceutical Co., Ltd. (SZSE:002900) CEO Jian Fei Qin's Holdings Dropped 13% in Value as a Result of the Recent Pullback
Kazakh Sanlian (002900.SZ): 2023 equity distribution, 10 distributions of 2 yuan, share registration date June 4
On May 28, Ge Longhui (002900.SZ) announced that the company's 2023 equity distribution plan is to distribute RMB 2.000000 in cash (tax included) to all shareholders for every 10 shares based on the company's total share capital up to now of 316,390,050 shares. The share registration date for this equity distribution is June 4, 2024, and the ex-dividend date is June 5, 2024.
We Think That There Are More Issues For Harbin Medisan Pharmaceutical (SZSE:002900) Than Just Sluggish Earnings
Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation
No Data